Sufentanil
Brand names: Sufenta, Dsuvia (sublingual)
Sufentanil is a potent synthetic opioid used for analgesia during anaesthesia and, in some settings, for neuraxial and acute pain management.
Adult dose
Dose auto-extracted from US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to sufentanil (e.g. anaphylaxis)
Side effects
- Apnoea
- Skeletal muscle rigidity
- Bradycardia
- Respiratory depression
- Hypotension
Interactions
- CYP3A4 inhibitors (e.g. macrolide antibiotics, azole antifungals, protease inhibitors): increased/prolonged opioid effects - consider dose reduction
- Benzodiazepines and other CNS depressants: profound sedation, respiratory depression, coma, death
- Serotonergic drugs: risk of serotonin syndrome
Clinical monograph
How it works
It is a highly potent selective mu-opioid receptor agonist, producing profound analgesia and dose-dependent central nervous system depression.
Prescribing in practice
- Owing to its high potency it causes profound dose-dependent respiratory depression and must be used only where airway management and ventilatory support are immediately available.
- Effects, including respiratory depression, are potentiated by other central nervous system depressants and can outlast a single opioid antagonist dose, requiring continued observation.
- It can cause bradycardia, hypotension and muscle rigidity, particularly with rapid administration.
Monitoring
Continuous monitoring of respiration, oxygenation and haemodynamics is required during and after administration.
Counselling the patient
- This is a very potent opioid given by trained anaesthetic staff with close monitoring.
- Drowsiness and slowed breathing can occur and are watched for closely.
Evidence & guidelines
Its high potency and use as an opioid analgesic in anaesthesia are well established and described in the SPC.
Reference: OAA Guidelines on Labour Analgesia; Miller's Anaesthesia 9th Ed; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Morphine Milligram Equivalents (MME) Calculator · Pain / Opioids
- Opioid Conversion / Equianalgesic Guide · Pain Management
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- Finnegan Neonatal Abstinence Scoring Tool (FNAST) · Neonatal Abstinence Syndrome
- Modified Finnegan Neonatal Abstinence Score (NAS) · Neonatal
- Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal · Critical Care